UNITED THERAPEUTICS Corp Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2010 to Q3 2024.
  • UNITED THERAPEUTICS Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 48.4M shares, a 2.62% decline year-over-year.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 49.7M shares, a 2.47% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 48.5M shares, a 2.54% increase from 2021.
  • UNITED THERAPEUTICS Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 47.3M shares, a 6.05% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 48.4M -1.3M -2.62% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 47.5M -2M -4.04% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 49.7M +100K +0.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 49.7M +1.2M +2.47% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 49.7M +1M +2.05% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 49.5M +1.4M +2.91% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 49.6M +1.9M +3.98% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 48.5M +1.2M +2.54% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 48.7M +1.1M +2.31% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 48.1M +800K +1.69% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 47.7M +1.3M +2.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 47.3M +2.7M +6.05% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 47.6M +3M +6.73% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 47.3M +2.9M +6.53% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 46.4M +2.3M +5.22% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 44.6M +800K +1.83% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-22
Q3 2020 44.6M +600K +1.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 44.4M +400K +0.91% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 44.1M +400K +0.92% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 43.8M -200K -0.46% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 44M 0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-28
Q2 2019 44M +600K +1.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 43.7M -200K -0.46% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 44M -900K -2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 44M -100K -0.23% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 43.4M -1.5M -3.34% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 43.9M -2M -4.36% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 44.9M -1.9M -4.06% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 44.1M -2.1M -4.55% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 44.9M -2M -4.26% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 45.9M -2.8M -5.75% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 46.8M -4.4M -8.59% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 46.2M -4M -7.97% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-25
Q2 2016 46.9M -5M -9.63% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-27
Q1 2016 48.7M +2M +4.28% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q4 2015 51.2M -3M -5.54% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-21
Q3 2015 50.2M +2.9M +6.14% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 51.9M -1.35M -2.54% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 46.7M -9.96M -17.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 54.2M +969K +1.82% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-22
Q3 2014 47.3M -6.39M -11.9% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 53.3M +604K +1.15% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-28
Q1 2014 56.7M +4.28M +8.17% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 53.2M -49K -0.09% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 53.7M +98K +0.18% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 52.6M -1.29M -2.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-29
Q1 2013 52.4M -2.63M -4.79% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 53.3M -6.12M -10.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 53.6M -7.62M -12.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 53.9M -8.81M -14% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 55M -7.61M -12.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-25
Q4 2011 59.4M -121K -0.2% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 61.2M +994K +1.65% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 62.8M +2.36M +3.91% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-26
Q1 2011 62.6M +2.6M +4.34% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 59.5M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 60.2M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 60.4M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 60M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.